Brief: Oncocyte And Burning Rock Execute Strategic Agreement To Distribute Determarx In China
Dec 15 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* ONCOCYTE AND BURNING ROCK EXECUTE STRATEGIC AGREEMENT TO
DISTRIBUTE DETERMARX IN CHINA
* ONCOCYTE CORP - EXCLUSIVE AGREEMENT INCLUDES PAYMENTS OF
UP TO
$6M IN FIRST YEAR AND ONGOING PER TEST FEES
Source text for Eikon: ID:nGNXg1Q2h
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer